Epidemiological studies have also demonstrated the relationship between the uric acid and MS [5] and individual components of metabolic syndrome such as obesity, hypertension, dyslipidemia, [6], insulin resistance, higher C-reactive protein (CRP) concentration [7], and endothelial dysfunction [8]. This evidence concerns the gene CRP and myeloid sarcoma.